Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study

Autor: Ornstein, Moshe C *, Pal, Sumanta K, Wood, Laura S, Tomer, Jackie M, Hobbs, Brian P, Jia, Xuefei S, Allman, Kimberly D, Martin, Allison, Olencki, Thomas, Davis, Nancy B, Gilligan, Timothy D, Mortazavi, Amir, Rathmell, W Kimryn, Garcia, Jorge A, Rini, Brian I
Zdroj: In The Lancet Oncology October 2019 20(10):1386-1394
Databáze: ScienceDirect